Is Nature a Good Journal? What the Data and Editorial Model Tell You

Nature's editors are full-time professionals, not working academics. They read dozens of submissions per week and decide within minutes whether yours merits a deeper look. The median first decision is 7 days, but many desk rejections arrive in 2-3 days.

The question they're answering isn't "is this good science?" It's "will this change how people outside this field think?"

That distinction matters. A paper can be technically flawless and still get desk-rejected in under 48 hours because the result, while important to specialists, doesn't cross the threshold of broad surprise. The editors have described this internally as the "dinner party test", could you explain why this result matters to a smart non-specialist over dinner and have them genuinely care?

What survives the desk:

• Results that are genuinely surprising to scientists across fields, not just within one subfield
• Complete stories where the data already supports the full claim (no "promising but needs more work")
• Papers that feel like scientific events, the kind that get discussed at departmental seminars across disciplines the week they publish

What gets desk-rejected in 7 days:

• Excellent specialist work that doesn't travel beyond one subfield (this is the #1 rejection reason)
• Results that are strong but not surprising, advances that move the field forward incrementally rather than reshaping how people think
• Papers where the broad significance only exists in the cover letter, not in the data
• Submissions from Nature rejections that were forwarded to Nature again without fundamental rethinking

Before submitting to Nature, answer these honestly:

1. Would a scientist in a completely different field find this interesting? Not "could you explain it to them", would they independently care about the result?
2. Is the finding genuinely surprising? Not just new, but surprising. Does it overturn an assumption or reveal something nobody expected?
3. Is the story complete? No obvious missing experiments, no "we plan to validate in human samples" caveats
4. Would this be news? If Nature published it tomorrow, would science journalists write about it?

If all four answers are yes, submit to Nature. If even one is no, Nature Communications, Science, Cell, or a field flagship is probably the more honest target, and a faster path to publication.

Nature papers are career-defining. A first-author Nature paper can win faculty positions, grants, and speaking invitations that no other single publication can. But the 93% desk rejection rate means most submissions cost 1-2 weeks and produce nothing.

The strategic question: Is the potential career upside worth the expected 93% chance of rejection and 1-2 week delay? For a truly paradigm-shifting result, yes. For a very strong result that's not quite cross-field paradigm-shifting, submitting to Nature Communications directly saves time and signals honest calibration to editors.

Before submitting, a Nature framing and scope check can assess whether your paper's cross-field significance is strong enough for Nature or better positioned for Nature Communications.

Last verified against Nature author guidelines and JCR 2024 data (IF 48.5, JCI 11.12, Q1, rank 2/135 in Multidisciplinary Sciences).

Nature desk-rejects 93% of submissions, typically within 7 days. The most common reasons: the abstract front-loads context instead of the cross-field finding, the paper still needs one more experiment to close the story, or the cover letter doesn't explicitly argue for Nature over the top specialty journal. A Nature submission readiness check identifies which of these gaps apply before you submit to a journal where most rejections happen before any reviewer sees the paper.

In our pre-submission review work with manuscripts targeting Nature, three patterns generate the most consistent desk rejections among the papers we analyze.

Abstract frames the scientific context, not the cross-field surprise. Nature editors have described their triage question as whether the result would "make a scientist in a different field stop and read." The most common failure we see: abstracts that build technical context for the first 2-3 sentences before stating the finding. By the time the finding appears, a generalist editor has already formed an opinion. Papers that open with the finding itself, stated in terms a non-specialist can immediately grasp, perform better at the triage stage. The significance needs to be front-loaded, not earned by reading.

Complete story means no qualifying experiments. Nature editors explicitly decline papers that contain caveats about validation in additional systems, planned follow-up experiments, or findings presented as preliminary. We find this is one of the most common mismatch patterns: authors who have a genuinely strong result but haven't finished the last 15-20% of the work that makes the story airtight. A Nature paper has to be complete enough that reviewers cannot reasonably request "one more experiment" that would change the conclusion.

Cover letter argues for Nature over the field flagship. The editors at Nature are full-time professionals receiving work from every discipline. They need the cover letter to make a specific argument: not "this is important work" but "this is important work that belongs in Nature rather than [top field journal]." Authors who don't make that comparative case explicitly are leaving the triage judgment entirely to the editor, who has limited time and will default to desk rejection when the argument isn't made.

SciRev community data confirms the 7-day median first decision, with most desk rejections arriving in 2-3 days. Handling quality rates 3.8/5.0. The speed means the entire triage decision is made from the abstract and cover letter alone in most cases.

Through our Nature desk-rejection pattern analysis, we've analyzed manuscripts targeting Nature. The answer to "is Nature a good journal?" is always yes. The real question is whether your paper is a Nature-level paper, and that's where most authors miscalibrate.